원문 보기
The stock market is displaying a chaotic web of conflicting signals ahead of second- quarter earnings, and the technology sector has already felt the pinch. The brutal rotation in the tech sector has led to the downfall of leading AI companies, leaving private investors in a state of uncertainty. But while the crowd panics, Wall Street's most controversial visionary is aggressively implementing a multi-million dollar strategy.
Katie Wood, founder of ARK Invest and the inspiration behind the legendary 2020 success that cemented her active management philosophy in the field of disruptive innovation, reviews her portfolio with cold, measured precision . In a series of decisive moves before mid-July 2026, Wood's flagship funds aggressively reduced their holdings in former favorites, selling more than $23 million in Advanced Micro Devices (AMD) shares and conducting a massive liquidation of Roku assets.
Instead of cashing in, Wood is redirecting capital to promising areas, demonstrating his trademark boldness to buy on dips. ARK has bought huge stakes in two dominant AI giants and one AI-based healthcare innovator. This is not just a rebalancing. This is a direct window into where the next wave of exponential wealth is being generated.
Wood's willingness to embrace short-term volatility in order to capture larger, longer-term trends is a cornerstone of her investment DNA. In this video, we break down the hard numbers behind ARK's latest transactions and set the stage for an analysis of three specific high- growth stocks that align with its bold, renewed vision.
If you want to invest like “smart money,” you can’t miss this. Let's get started. Let's start with the main gem of our discussion— Space Exploration Technologies Corp., trading under the ticker symbol SPCX. Wood recently made her largest transaction to date, investing more than $52 million to purchase 349,000 shares for her funds.
While the general public still perceives this giant primarily as a rocket and satellite business, the smartest minds on Wall Street realize that SpaceX has aggressively transformed itself into a powerhouse in the field of AI infrastructure. After a monumental initial public offering (IPO), a classic cooling-off period saw the price fall to around $152 per share, 32.6% below its June high of $225.6.
This price correction has nothing to do with deteriorating fundamentals. Rather, it is a healthy cooling of speculative excitement driven by broader market concerns about the macro economy and the temporary dynamics of equity unblocking. SpaceX's structural advantage lies in its multi-layered, vertically integrated business model.
The dominant Starlink satellite internet provides a solid financial base, while the launch division maintains a near-monopoly position in orbital logistics. But the real explosive catalyst is the company's sudden ascension to the role of the main " landlord" in the AI field. Having absorbed Elon Musk's XAI project earlier this year and struck a stunning $ 60 billion in stock deal to buy Cursor, a leading AI programming assistant with over $4 billion in annual revenue.
SpaceX bypassed a long development cycle to capture a significant share of the enterprise AI market. This massive infrastructure shift is already bearing fruit with the joint launch of the Grok 4.5 Frontier model, which delivers unprecedented token efficiency and reduces developer costs by more than four times compared to major competitors.
As global corporations demand significant reductions in token costs, SpaceX’s vast computing power, based on the colossal Colossus supercomputer cluster, equivalent to a million H100 chips, puts the company in a league of its own. Moreover, its roadmap for the future foresees the tremendous potential of orbital data centers in space.
This radical approach could completely eliminate the limitations of terrestrial power supply and cooling, fundamentally changing the economics of global AI. While current financials still show temporary capital-intensive losses, conservative projections point to revenue growth from an expected $39 billion in 2026 to an impressive $ 365 billion by 2030, with AI accounting for over 90% of the total business.
Trading at a deep discount of 13.4 times projected 2030 earnings versus the tech sector average of 25 times , SpaceX presents an extremely attractive long-term growth story for investors willing to take advantage of a significant market pullback. Moving from orbital heights to the cutting edge of biological computing, our second asset is pharmaceutical titan Eli Lilly, trading under the ticker symbol LLY, which has received a $ 25.8 million investment from ARK Invest.
While mainstream media is focused on the success of blockbuster weight loss drugs Mounjaro and Zepbound, savvy investors are looking at a much larger secondary effect. Lilly is channeling historical cash flows from its dominant obesity treatment franchise into building an AI platform for drug development and manufacturing.
The business effectively entered a self-reinforcing flywheel mode, evolving as a hyper-growth tech company while maintaining a gross margin structure of 80%. Let's look at the actual data. In fiscal year 2025, Eli Lilly's revenue grew 45% year-over-year to $65 billion . This momentum accelerated dramatically in the first quarter of 2026, with revenue rising 56% to $19.8 billion and GAAP earnings per share soaring 170%.
As a result, management raised its full-year 2026 revenue forecast to a staggering $82–85 billion. Looking ahead, revenue is expected to approach $100 billion in 2027 , with free cash flow reaching $ 30 billion. Instead of stopping, Lilly is spending billions on research, development, and capital investment to create the most powerful AI supercomputer in the pharmaceutical industry in collaboration with Nvidia.
This massive computing power, combined with their Tune Lab platform, which contains over $1 billion in proprietary clinical data sets, allows Lilly to operate as a scalable biomedical search engine, using artificial intelligence to optimize drug development and deploy robotic digital twins in their manufacturing facilities.
They significantly scale bandwidth. Even a small 1% improvement in throughput on a $100 billion revenue base unlocks an additional $1 billion in revenue, which translates into $800 million in gross profit. If Lilly uses AI to achieve a 500 basis point margin expansion, revenue could grow to $ 170 billion by 2030, and free cash flow could reach $ 60 billion.
By using its obesity drug empire to fund the artificial intelligence revolution, Eli Lilly is quietly transforming itself into a top biomedical investor. Now let's shift our focus to a tech giant that is rapidly leveraging consumer scale to build an invincible infrastructure fortress. Our third stock , which recently received a significant $ 20.7 million stake increase from Katie Wood’s ETF.
Earlier this year, Wall Street panicked when Meta raised its capital spending forecast for the year to a range of $125 billion to $145 billion. But with a forward P/E ratio just below 20, Meta is the cheapest of the big four hyperscalers, and its valuation will fall to an incredibly cheap 16 by fiscal 2028 .
The market is finally realizing that this staggering capital expenditure is not wasted money. This is a huge asset that can be rented out. The long-awaited launch of MetaCloud marks a monumental shift, allowing Meta to sell computing power and host models to third-party enterprises. Analysts suggest that leasing just one gigawatt of capacity could generate over $20 billion in revenue, which at an estimated operating margin of 85% translates to a whopping $17 billion in operating profit.
Additionally, Meta is implementing a ruthless pricing strategy to capture enterprise market share along with its new Muse creative imaging model. The company recently released its improved Authentic Muse Spark 1.1 model, offering a public API with pay-as-you- go pricing at $1.25 per million input tokens.
This is approximately 25% of the cost charged by premium competitors such as OpenAI and Anthropic, which is a direct attack on the B2B AI space. Even if Meta decides to host competitor models or partner with Frontier Labs, it has an unbeatable trump card —a distribution ecosystem of 3.56 billion daily active users.
This massive scale, combined with a 52% operating margin across its core family of apps, ensures that Meta is monetizing AI faster than almost anyone else. By positioning itself as both an AI software distributor and infrastructure lessor, Meta is poised for a major reassessment. Wood's latest moves indicate a move away from legacy equipment and toward highly profitable AI platforms.
Keep these three options in mind. Be sure to click the subscribe button, like, and write the name of your favorite promotion in the comments. Until next time, be vigilant and trade wisely.
댓글 0